How Do You Synthesize Evidence When Average Effects Hide Important Subgroup Differences?

What if the average effect does not represent everyone?

A meta-analysis reports a modest average benefit. Looking more closely, however, the intervention appears highly beneficial for one group, ineffective for another, and perhaps harmful for a third.

Should the overall effect still be your main conclusion?

Possibly, but not automatically. Average effects summarize a population. They do not prove that every individual or subgroup experiences the same relative or absolute effect. Genuine effect modification can matter greatly for practice and policy.

The difficulty is that subgroup analyses are also unusually good at producing persuasive patterns by chance. A responsible synthesis therefore has to take heterogeneity seriously without treating every subgroup difference as real.

Investigate subgroup differences, but demand stronger evidence before believing them

An average effect is a summary, not a promise of uniformity

What does an average effect actually tell you?

Suppose a meta-analysis estimates that an intervention reduces an outcome by an average of 15% relative to the comparator. That summary describes the effect represented by the included evidence under the model used.

It does not establish that every participant experiences a 15% reduction. Nor does it prove that the true relative effect is identical across age groups, baseline risk levels, settings, intervention variants, or other characteristics.

Variation in effects can arise because an intervention genuinely works differently under different conditions. This is often described as effect modification or heterogeneity of treatment effects.

Different absolute effects do not necessarily mean different relative effects

This distinction is crucial.

Imagine that an intervention reduces relative risk by approximately the same proportion in both high-risk and low-risk groups. Because the high-risk group begins with more events, the same relative reduction can produce a much larger absolute benefit in that group.

That is not necessarily evidence that the intervention has a different relative effect across subgroups. It may simply reflect different baseline risks.

For decisions, those differences in absolute benefit can still be extremely important. Methodological work on subgroup interpretation has emphasized that prognostic differences can create meaningful variation in absolute treatment effects even when relative effects remain similar.

“Significant here, not significant there” is not a test of subgroup difference

This is perhaps the most common subgroup error.

Suppose the intervention effect is statistically significant among younger participants but not among older participants. It does not follow that age modifies the intervention effect.

The correct question is whether the estimated effects differ from each other beyond what would reasonably be expected from sampling variation. That requires an appropriate interaction test or equivalent direct assessment of the difference between subgroup effects.

Methodological guidance consistently warns against comparing the statistical significance of separate subgroup estimates. Reviews should report how subgroup effects were compared, including whether an interaction test was used.

Subgroup analyses multiply opportunities for chance findings

If researchers divide participants by age, sex, baseline severity, prior treatment, location, socioeconomic status, adherence, and several other characteristics, some apparently striking differences may arise simply through repeated testing.

The more subgroup hypotheses examined after seeing the data, the easier it becomes to find a compelling story.

Credibility is therefore stronger when the subgroup hypothesis was specified in advance, when relatively few hypotheses were tested, and when the expected direction of effect was prespecified. Methodological assessments have found that subgroup claims in published trials often fail several established credibility criteria.

Within-study subgroup comparisons are generally more credible than between-study comparisons

Suppose you suspect that age modifies an intervention effect.

The strongest evidence would ideally compare younger and older participants within the same randomized studies. Because both subgroups arise within the same studies, many study-level characteristics are held constant.

A weaker approach might compare studies whose participants have an average age of 35 with entirely different studies whose participants have an average age of 70. Those studies may differ in setting, intervention implementation, eligibility criteria, follow-up, comparator, or numerous other characteristics.

An apparent relationship between average age and treatment effect could therefore reflect another difference between the studies. Contemporary GRADE guidance likewise regards within-study evidence of effect modification as substantially more compelling than comparisons based only on differences between studies.

Subgroups defined after treatment begins can be especially problematic

Subgroups based on baseline characteristics such as age or pre-intervention severity can be considered without being consequences of the assigned treatment.

Post-intervention characteristics are different. Suppose researchers divide participants according to whether they adhered well to treatment, completed the intervention, or remained in care for a particular duration. Treatment itself may influence those characteristics.

Comparisons based on such post-randomization variables can destroy the original comparability produced by randomization and generate misleading subgroup conclusions. Established credibility criteria therefore give much greater confidence to subgroup variables defined at baseline.

A plausible explanation helps, but does not prove the subgroup effect

A subgroup hypothesis is more credible when supported by prior evidence or a convincing rationale. For example, researchers may have strong reasons established before the study to expect an intervention to behave differently at different levels of baseline severity.

But plausibility cannot rescue weak empirical evidence. A compelling explanation constructed after an unexpected subgroup result can be particularly seductive because humans are quite good at explaining patterns once we already know they occurred.

This is another version of the broader problem of treating mechanistic plausibility as proof of an effect.

Consistency across studies strengthens subgroup claims

If several independent studies repeatedly show a similar interaction, the subgroup hypothesis becomes more credible than if it appeared once in a small analysis.

Consistency should concern the subgroup interaction itself, not merely whether the intervention works in the same subgroup repeatedly.

For example, showing benefit among younger participants in several studies does not establish that younger participants benefit more than older participants unless the evidence actually supports a difference in treatment effects between those groups.

Subgroup effects exist on a credibility continuum

No single criterion proves that a subgroup effect is real. Methodological frameworks therefore recommend considering several features together: whether the hypothesis was prespecified, whether the subgroup characteristic was measured at baseline, whether only a limited number of hypotheses were tested, whether an appropriate interaction analysis supports the difference, whether the effect is consistent across studies or related outcomes, and whether external evidence supports the hypothesis.

A subgroup finding satisfying many of these considerations deserves more confidence than an isolated post hoc finding among dozens of exploratory analyses.

The goal is not to ban exploratory subgroup analysis. Exploratory findings can generate valuable hypotheses. The problem begins when hypothesis-generating evidence is presented as though it were already confirmatory.

How can an average effect hide a potentially important subgroup difference?

The subgroup analysis has not replaced the overall effect. It has refined the question by asking whether the average conceals systematic variation that is sufficiently credible to matter.

Why subgroup findings are unusually easy to overinterpret

Ask whether the subgroup difference itself is credible

When a pooled effect appears to hide important variation, do not jump directly from subgroup-specific estimates to subgroup-specific conclusions. Evaluate the evidence for effect modification explicitly.

When reporting the synthesis, describe how subgroup variables were defined, whether hypotheses were prespecified, whether comparisons were within or between studies, how many subgroup hypotheses were investigated, and how the subgroup effects were statistically compared. Cochrane reporting guidance specifically calls for these details when subgroup analyses or meta-regression are used.

Above all, match the strength of your language to the credibility of the subgroup evidence. “The intervention is effective only for subgroup A” is a much stronger claim than “the available evidence suggests that effects may be larger in subgroup A.” The data have to earn the stronger sentence.

Before concluding that average effects hide a subgroup difference, check:

Common questions about average effects and subgroup differences

Do not assume the average applies equally to everyone, but do not abandon it for fragile subgroup findings

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.